Global Bulk Pricing Trends for 3-Bromo-5-Chloropicolinonitrile in 2026
- Market Outlook: Industrial demand is rising due to increased synthesis of kinase inhibitors and oncology intermediates.
- Cost Drivers: Halogenation reagent costs and purification complexity significantly influence the final bulk price.
- Supply Chain: Secure procurement requires verified global manufacturers with robust quality control systems.
The pharmaceutical intermediate market is undergoing significant shifts as we approach 2026, particularly for halogenated pyridine derivatives. 3-Bromo-5-chloropicolinonitrile (CAS: 760207-83-8) has emerged as a critical building block in the development of targeted therapies, including PROTAC degraders and kinase inhibitors. For procurement officers and process chemists, understanding the bulk price dynamics is essential for budgeting large-scale production runs. This analysis focuses on the technical and commercial factors defining the cost structure of this high-value intermediate.
Factors Influencing Industrial-Scale Procurement Costs
The pricing trajectory for 3-Bromo-5-chloropicolinonitrile is not solely determined by raw material availability but is heavily weighted by the complexity of the synthesis route. Producing this compound requires precise halogenation steps where regioselectivity is paramount. Unwanted isomers can form during the bromination and chlorination of the picolinonitrile core, necessitating rigorous purification protocols to achieve industrial purity standards typically exceeding 98% or 99% by HPLC.
Several key variables will dictate the cost per kilogram in 2026:
- Raw Material Volatility: The cost of brominating agents and chlorinated solvents fluctuates based on global chemical supply chains. Stability in these upstream markets is crucial for predictable pricing.
- Yield Optimization: Manufacturers who have optimized their reaction conditions to minimize byproduct formation can offer more competitive rates without sacrificing quality.
- Regulatory Compliance: Adherence to environmental safety standards regarding hazardous waste disposal from halogenation processes adds to the operational overhead.
Furthermore, the demand from the oncology sector continues to drive volume. As novel drug candidates move from clinical trials to commercialization, the need for metric-ton quantities increases. Buyers must account for these scale-up factors when negotiating contracts. When evaluating suppliers for 3-Bromo-2-cyano-5-chloropyridine, technical verification is paramount to ensure the material meets the strict specifications required for GMP synthesis.
Technical Specifications and Quality Assurance
In bulk procurement, the Certificate of Analysis (COA) is the primary document verifying quality. A reputable global manufacturer will provide comprehensive data including NMR, HPLC, and LC-MS profiles. For 3-Bromo-5-chloropicolinonitrile, specific attention must be paid to the residual solvent content and the ratio of isomeric impurities. High-performance liquid chromatography should confirm the absence of mono-halogenated precursors which can interfere with downstream coupling reactions.
Storage and stability are also critical cost considerations. This compound is sensitive to moisture and light. Improper packaging can lead to degradation, resulting in financial loss during long-term storage. Industrial packaging typically involves double-lined drums with desiccants to maintain integrity during ocean freight. Below is a summary of the standard safety and transport classification data associated with this chemical substance.
| Parameter | Specification / Classification |
|---|---|
| CAS Number | 760207-83-8 |
| Chemical Name | 3-Bromo-5-chloro-2-pyridinecarbonitrile |
| UN Number | UN2811 |
| Hazard Class | 6.1 (Toxic Substance) |
| Packing Group | III |
| Signal Word | Danger |
| Hazard Statements | H301, H315, H318, H335 |
| Typical Purity | >98.0% (HPLC) |
How to Request Custom Quotes from Verified Manufacturers
Securing a stable supply chain for 2026 requires engaging directly with production facilities rather than trading intermediaries. Direct engagement ensures transparency regarding the manufacturing process and allows for customization of packaging sizes, ranging from kilogram-scale drums to metric-ton isotanks. Buyers should request recent batch records to verify consistency in production yields.
When contacting suppliers, specify your required purity levels and intended application. This allows the manufacturer to recommend the appropriate grade, potentially optimizing costs. For instance, research-grade material may require additional analytical documentation compared to technical-grade bulk used for early-stage process development. It is also advisable to inquire about lead times and inventory levels, as halogenated intermediates often have longer production cycles due to safety protocols.
Partnering for Long-Term Supply
Reliability is the cornerstone of industrial chemical procurement. NINGBO INNO PHARMCHEM CO.,LTD. stands out as a premier partner for organizations requiring high-purity organic synthesis intermediates. With a focus on technical excellence and scalable production capabilities, they ensure that clients receive material that meets rigorous international standards. By aligning with a dedicated manufacturer, companies can mitigate the risks associated with market volatility and supply chain disruptions.
In conclusion, the bulk price for 3-Bromo-5-chloropicolinonitrile in 2026 will reflect the balance between raw material costs and the technical expertise required for its synthesis. Procurement strategies should prioritize quality assurance and supplier reliability over lowest-cost options to prevent downstream processing failures. By understanding the technical nuances and safety requirements, buyers can secure a competitive advantage in their drug development pipelines.